NovoCure Ltd

Ownership Transactions Reported by 25 Insiders

	Insiders	Shares	%	Avg Price	Total $
Buys	0
Sells	8	-17.6K	100%	$18.82	-$331K
Net	-8	-17.6K	-100%		-$331K

Name	Relationship	Holdings Value	Past Year Net Change	Change %	Report Date
William F. Doyle	Executive Chairman, Director	$6.97M			Aug 2, 2022
Danziger Asaf	Director	$6.13M			Jan 1, 2025
Cordova Ashley	Chief Executive Officer	$5.79M	-$13.9K	-0.24%	Dec 31, 2024
Groenhuysen Wilhelmus Cm	Chief Operating Officer	$5.26M	-$90.4K	-1.69%	Jun 28, 2024
Leonard Frank X	EVP, Pres., Novocure Oncology	$5.12M	-$83.4K	-1.6%	Nov 1, 2024
Weinberg Uri	Chief Innovation Officer	$4.83M			Feb 27, 2024
W. Anthony Vernon	Director	$4.04M	-$23K	-0.57%	Jun 4, 2024
Ben Arye Barak	General Counsel	$3.79M			Dec 31, 2024
Puri Michal Nath	Chief Human Resources Officer	$3.52M	-$12.8K	-0.36%	Oct 31, 2024
Giladi Moshe	Chief Science Officer	$2.41M			Feb 27, 2024
Leupin Nicolas	Chief Medical Officer	$2.11M			Feb 27, 2024
Leung Gabriel	Director	$1.97M	-$23K	-1.16%	Jun 4, 2024
Paravasthu Mukund	Chief Operating Officer	$1.6M	-$61.2K	-3.68%	Jan 11, 2025
Pritesh Shah	Chief Growth Officer	$1.58M			Nov 7, 2023
Todd Longsworth	General Counsel	$860K			Mar 8, 2022
Burke William Patrick	Chief Human Resources Officer	$841K			Jun 30, 2023
Martin Madden	Director	$572K			Jun 5, 2024
Ely Benaim	Chief Medical Officer	$364K			Jan 6, 2023
Stafford Kristin	Director	$198K			Jun 5, 2023
Timothy J. Scannell	Director	$172K	-$23K	-11.8%	Jun 4, 2024
Brackmann Christoph	Cfo	$165K			Jan 1, 2025
Hung David	Director	$102K			Jun 5, 2024
Jeryl L. Hilleman	Director	$102K			Jun 5, 2024
Allyson J. Ocean	Director	$102K			Jun 5, 2024
Sherilyn S. McCoy	Director	$17.2K			Jun 9, 2021

Insider	Symbol	Class	Transaction	%	Value $	* Price $	Shares	Shares Owned	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.